Loading... 2 0 20 0 false
Credit Name
Matthew Wong
Full Name
Wong, Matthew
Loading... 3 0 20 0 false


Results 1-12 of 12 (Search time: 0.006 seconds).

PreviewIssue DateTitleAuthor(s)
129-Mar-2024Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapseTong, ElissaHorsley, PatrickWheeler, HelenWong, Matthew Venkatesha, VenkateshaChan, JosephKastelan, MarinaBack, Michael 
2Jan-2022Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapyJayamanne, Dasantha Wong, Matthew Back, Michael Metz, G.Wheeler, H.Cook, R.Little, N.Parkinson, J.Kastelan, M.Brown, C.
39-Jun-2021Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastomaCook, Theresa A Jayamanne, Dasantha Wong, Matthew Cove, Nicola Back, Michael Wheeler, H.Parkinson, J.Cook, R. J.Kastelan, M. A.Brown, C.
4Mar-2020The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade gliomaWong, Matthew Jayamanne, Dasantha Back, Michael Chan, J.Wheeler, H.Khasraw, M.Kastelan, M.Guo, L.
5Jun-2019Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic gliomaJayamanne, Dasantha Wong, Matthew Back, Michael Back, E.Kastelan, M.Khasraw, M.Brown, C.Wheeler, H.
6May-2019Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastomaCuncannon, Moire Wong, Matthew Jayamanne, Dasantha Cove, Nicola Back, Michael Guo, L.Wheeler, H.
7Apr-2019Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementBack, Michael Jayamanne, Dasantha Wong, Matthew Brazier, D.Newey, A.Bailey, D.Schembri, GHsiao, E.Khasraw, M.Kastelan, M.Guo, L.Clarke, S.Wheeler, H.
8Apr-2019Pattern of failure in anaplastic glioma patients with an IDH1/2 mutationBack, Michael Jayamanne, Dasantha Wong, Matthew Brazier, D.Newey, A.Bailey, D.Schembri, G.Hsiao, E.Khasraw, M.Kastelan, M.Brown, C.Wheeler, H.
9Oct-2018Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer CentreBack, Michael Jayamanne, Dasantha Wong, Matthew Cove, N.Wheeler, H.Khasraw, M.Guo, L.Back, J.
10Sep-2017Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centreWong, Matthew Kneebone, Andrew Itchins, M.Arena, J.Nahm, C.B.Rabindran, J.Kim, S.Gibbs, E.Bergamin, S.Chua, T.C.Gill, Anthony J Maher, R.Diakos, C.Mittal, A.Hruby, G.Pavlakis, N.Samra, J.Clarke, S.
11Jul-2016Upstream and downstream co-inhibition of mitogen-activated protein kinase and PI3K/Akt/mTOR pathways in pancreatic ductal adenocarcinomaWong, Matthew Xue, A.Baxter, R.C.Pavlakis, N.Smith, R.C.
12Jun-2016Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Wong, Matthew Chan, D.L.Lee, A.Li, B.T.Lumba, S.Clarke, S.J.Samra, J.Pavlakis, N.